Which institution holds the most shares in I-Mab ADR (IMAB)

I-Mab ADR (NASDAQ: IMAB) is -5.79% lower on its value in year-to-date trading and has touched a low of $1.16 and a high of $5.29 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IMAB stock was last observed hovering at around $2.00 in the last trading session, with the day’s loss setting it -0.21%.

Currently trading at $1.79, the stock is -2.99% and 2.13% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.77 million and changing -10.50% at the moment leaves the stock -17.21% off its SMA200. IMAB registered -64.34% loss for a year compared to 6-month loss of -30.08%. The firm has a 50-day simple moving average (SMA 50) of $1.01 and a 200-day simple moving average (SMA200) of $0.11.

Invest Like Buffett: Travel Back in Time & Grab This High-Potential Stock Before It Explodes

Imagine buying Apple for $1, Amazon for $2, or Tesla for $3. Now, imagine the same opportunity with a hidden gem trading under $3 right now.

Our premium newsletter, powered by AI and expert analysis, uncovers these time-travel investment opportunities.

Invest like Buffett and profit from undervalued gems before the market catches on.

Limited-time offer: Get your first month for just $2.90 and start your journey to wealth creation.


The stock witnessed a -20.09% gain in the last 1 month and extending the period to 3 months gives it a 11.18%, and is -1.65% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.76% over the week and 10.29% over the month.

Distance from 52-week low is 54.31% and -66.16% from its 52-week high.

I-Mab ADR quarterly earnings per share for the current quarter are estimated at $0.The EPS is expected to grow by 11.53% this year

72 institutions hold shares in I-Mab ADR (IMAB), with institutional investors hold 54.78% of the company’s shares. The shares outstanding are 82.27M, and float is at 81.69M with Short Float at 1.85%. Institutions hold 54.34% of the Float.

The top institutional shareholder in the company is HHLR Advisors, LTD with over 6.91 million shares valued at $20.66 million. The investor’s holdings represent 8.36% of the IMAB Shares outstanding. As of Jun 29, 2023, the second largest holder is Vanguard Group Inc with 2.12 million shares valued at $6.32 million to account for 2.56% of the shares outstanding. The other top investors are Blackrock Inc. which holds 2.06 million shares representing 2.49% and valued at over $6.16 million, while Artal Group S.A. holds 1.03% of the shares totaling 0.85 million with a market value of $2.54 million.

I-Mab ADR (IMAB): Who are the competitors?

One of the company’s main competitors (and peers) include Johnson & Johnson (JNJ) that is trading -3.55% down over the past 12 months.Eli Lilly & Co. (LLY) lies in the list of competitors of the I-Mab ADR and is 113.17% higher over the same period from IMABMerck & Co. Inc. (MRK) is 16.62% up on the 1-year trading charts.